<DOC>
	<DOCNO>NCT01242891</DOCNO>
	<brief_summary>The main purpose protocol provide mechanism continue access patient would enrol primary cohort IDE study .</brief_summary>
	<brief_title>Assess Safety Probable Benefit EXCOR® Pediatric Ventricular Assist Device Under Continued Access Protocol</brief_title>
	<detailed_description>The data collection protocol study remain consistent main IDE study EXCOR® Pediatric Ventricular Assist Device . This protocol close time main IDE study due FDA approval ( December 16 , 2011 ) .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Cardiomyopathies</mesh_term>
	<criteria>Severe New York Heart Association ( NYHA ) Functional Class IV ( Ross Functional Class IV patient &lt; = 6 year ) heart failure refractory optimal medical therapy , meet least one follow criterion : INTERMACS profile status 1 1A , i.e . critical cardiogenic shock ( low BP unresponsive support ) , compromised end organ perfusion , &lt; 24 hour survival without mechanical support ; may due Ventricular Tachycardia ( VT ) /Ventricular Fibrillation ( VF ) ( 1A ) OR INTERMACS profile status 2A ( i.e progressive decline ) : imminent danger , worsen despite optimal inotropic therapy ; may due VT/VF ( 2A ) AND least one follow criterion : Decline renal function , Decline nutritional status , Decline mobility/ambulation OR Support extracorporeal membrane oxygenation ( ECMO ) mechanical circulatory support device OR Unable separate cardiopulmonary bypass Listed ( UNOS status 1A equivalent ) cardiac transplantation Twoventricle circulation , include cardiomypathy , repair structural heart disease acquire heart disease Age 0 16 year Weight &gt; = 3 kg &lt; = 60 kg Legal guardian ( patient ageappropriate ) understand nature procedure , willing comply associate followup evaluation , provide write informed consent assent prior procedure . Support ECMO &gt; = 10 day Cardiopulmonary resuscitation ( CPR ) duration &gt; = 30 minute within 48 hour implantation Body weight &lt; 3.0 kg Body Surface Area &gt; 1.5 m2 Presence mechanical aortic valve Unfavorable technicallychallenging cardiac anatomy include single ventricle lesion , complex heterotaxy , restrictive cardiomyopathy Evidence intrinsic hepatic disease Evidence intrinsic renal disease Evidence intrinsic pulmonary disease Hemodialysis peritoneal dialysis ( include dialysis continuous venovenous hemofiltration ( CVVH ) fluid removal ) Moderate severe aortic and/or pulmonic valve insufficiency Apical VSD compromise technically challenge repair implant Documented heparin induce thrombocytopenia ( HIT ) Documented coagulopathy Hematologic disorder Active Infection within 48 hour implant ( positive blood culture White Blood Cell count &gt; 15,000 fever &gt; 38 degree C ) Documented Human immunodeficiency virus ( HIV ) infection acquire immunodeficiency syndrome ( AIDS ) Evidence recent lifelimiting malignant disease Stroke within 30 day prior enrollment Psychiatric behavioral disease Currently participate another IDE IND trial Patient pregnant nursing</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>16 Years</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>Ventricular Assist Device</keyword>
	<keyword>Pediatric Ventricular Assist Device</keyword>
</DOC>